Abstract
Purpose of Review
The Maillard reaction (MR) is a non-enzymatic reaction between reducing sugars and compounds with free amino groups such as proteins and takes place during thermal processing and storage of foods. This review aims to discuss potential effects of dietary MR products on the pathological mechanisms of allergic diseases.
Recent Findings
Since the MR leads to modification of proteins with various types of glycation structures, the impact of the MR on the immunogenicity and potential allergenicity of food proteins in many allergenic foods has been assessed. In addition, recent studies have suggested that the MR products, in particular “advanced glycation end products (AGEs),” contained in the diet may be involved in the development of chronic inflammation by acting as inflammatory components and affecting the gut microbiome.
Summary
This review found that the biological, immunological, and allergic properties of dietary MR products are diverse due to the complexity of the MR.
Similar content being viewed by others
Abbreviations
- AGEs:
-
Advanced glycation end product
- CML:
-
Nε-Carboxymethyl-lysine
- CKD:
-
Chronic kidney disease
- DAMP:
-
Damage-associated molecular pattern
- DCs:
-
Dendritic cells
- MR:
-
Maillard reaction
- PRR:
-
Pattern recognition receptor
- RAGE:
-
The receptor for the advanced glycation end products
- SCFA:
-
Short chain fatty acid
- SR:
-
Scavenger receptor
- TDM1:
-
Type 1 diabetes
- TDM2:
-
Type 2 diabetes
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Hellwig M, Henle T. Baking, ageing, diabetes: a short history of the Maillard reaction. Angew Chem Int Ed Engl. 2014;53(39):10316–29.
Berrens L. Neoallergens in heated pecan nut: products of Maillard-type degradation? Allergy. 1996;51:277–8.
Toda M, Heilmann M, Ilchmann A, et al. The Maillard reaction and food allergies: is there a link? Clin Chem Lab Med. 2014;52(1):61–7.
Gupta RK, Gupta K, Sharma A, Das M, Ansari IA, Dwivedi PD. Maillard reaction in food allergy: pros and cons. Crit Rev Food Sci Nutr. 2018;58(2):208–26.
Teodorowicz M, van Neerven J, Savelkoul H. Food processing: the influence of the Maillard reaction on immunogenicity and allergenicity of food proteins. Nutrients. 2017;9(8):835
Scheurer S, Lauer I, Foetisch K, Moncin MSM, Retzek M, Hartz C, et al. Strong allergenicity of Pru av 3, the lipid transfer protein from cherry, is related to high stability against thermal processing and digestion. J Allergy Clin Immunol. 2004;114(4):900–7.
Vissers YM, Iwan M, Adel-Patient K, Stahl Skov P, Rigby NM, Johnson PE, et al. Effect of roasting on the allergenicity of major peanut allergens Ara h 1 and Ara h 2/6: the necessity of degranulation assays. Clin Exp Allergy. 2011;41(11):1631–42.
Cucu T, De Meulenaer B, Bridts C, et al. Impact of thermal processing and the Maillard reaction on the basophil activation of hazelnut allergic patients. Food Chem Toxicol. 2012;50(5):1722–8.
Zani IA, Stephen SL, Mughal NA, Russell D, Homer-Vanniasinkam S, Wheatcroft S, et al. Scavenger receptor structure and function in health and disease. Cell. 2015;4(2):178–201.
Ramasamy R, Yan SF, Schmidt AM. Advanced glycation endproducts: from precursors to RAGE: round and round we go. Amino Acids. 2012;42(4):1151–61.
Sakaguchi M, Kinoshita R, Putranto EW, et al. Signal diversity of receptor for advanced glycation end products. Acta Med Okayama. 2017;71(6):459–65.
•• Ilchmann A, Burgdorf S, Scheurer S, et al. Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II. J Allergy Clin Immunol. 2010;125(1):175–83 This study was the first to show that AGEs of a food allergen possess higher T cell immunogenicity than native form of molecule due to binding to SR-A expressed on the cell surface of DCs.
Heilmann M, Wellner A, Gadermaier G, Ilchmann A, Briza P, Krause M, et al. Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity. J Biol Chem. 2014;289(11):7919–28.
Perusko M, van Roest M, Stanic-Vucinic D, et al. Glycation of the major milk allergen β-lactoglobulin changes its allergenicity by alterations in cellular uptake and degradation. Mol Nutr Food Res. 2018;62(17):e1800341.
Buttari B, Profumo E, Capozzi A, Facchiano F, Saso L, Sorice M, et al. Advanced glycation end products of human β-glycoprotein I modulate the maturation and function of DCs. Blood. 2011;117(23):6152–61.
Rowan S, Bejarano E, Taylor A. Mechanistic targeting of advanced glycation end-products in age-related diseases. Biochim Biophys Acta Mol basis Dis. 2018;1864(12):3631–43.
Rojas A, Morales M, Gonzalez I, Araya P. Inhibition of RAGE axis signaling: a pharmacological challenge. Curr Drug Targets. 2018;19.
Ramasamy R, Shekhtman A, Schmidt AM. The multiple faces of RAGE-opportunities for therapeutic intervention in aging and chronic disease. Expert Opin Ther Targets. 2016;20(4):431–46.
Akirav EM, Henegariu O, Preston-Hurlburt P, Schmidt AM, Clynes R, Herold KC. The receptor for advanced glycation end products (RAGE) affects T cell differentiation in OVA induced asthma. PLoS One. 2014;9(4):e95678.
Durning SP, Preston-Hurlburt P, Clark PR, Xu D, Herold KC, Type 1 Diabetes TrialNet Study Group. The receptor for advanced glycation endproducts drives T cell survival and inflammation in type 1 diabetes mellitus. J Immunol. 2016;197(8):3076–85.
Henle T. AGEs in foods: do they play a role in uremia? Kidney Int Suppl. 2003;84:S145–7.
Poulsen MW, Hedegaard RV, Andersen JM, de Courten B, Bügel S, Nielsen J, et al. Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol. 2013;60:10–37.
Tessier FJ, Niquet-Léridon C, Jacolot P, Jouquand C, Genin M, Schmidt AM, et al. Quantitative assessment of organ distribution of dietary protein-bound 13C-labeled Nɛ-carboxymethyllysine after a chronic oral exposure in mice. Mol Nutr Food Res. 2016;60(11):2446–56.
•• Oczypok EA, Perkins TN, Oury TD. All the “RAGE” in lung disease: the receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses. Paediatr Respir Rev. 2017;23:40–9 This review article discusses the role of RAGE in the development of pulmonary inflammation including asthma.
Smith PK. Do advanced glycation end-products cause food allergy? Curr Opin Allergy Clin Immunol. 2017;17(5):325–31.
Smith PK, Masilamani M, Li XM, Sampson HA. The false alarm hypothesis: food allergy is associated with high dietary advanced glycation end-products and proglycating dietary sugars that mimic alarmins. J Allergy Clin Immunol. 2017;139(2):429–37.
Clarke RE, Dordevic AL, Tan SM, Ryan L, Coughlan M. Dietary advanced glycation end products and risk factors for chronic disease: a systematic review of randomised controlled trials. Nutrients. 2016;8(3):125.
Van Puyvelde K, Mets T, Njemini R, et al. Effect of advanced glycation end product intake on inflammation and aging: a systematic review. Nutr Rev. 2014;72:638–50.
Semba RD, Gebauer SK, Baer DJ, Sun K, Turner R, Silber HA, et al. Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial. J Nutr. 2014;144(7):1037–42.
Baye E, de Courten MP, Walker K, et al. Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial. Sci Rep. 2017;7(1):4123.
Calder CL, Ortega G, Vij A, Chawla K, Nnamdi-Emetarom C, Stephanie S, et al. Morbid obesity is an independent risk factor for postoperative renal dysfunction in young adults: a review of the American College of Surgeons National Surgical Quality Improvement Program database. Am J Surg. 2016;211(4):772–7.
Ott C, Jacobs K, Haucke E, Navarrete Santos A, Grune T, Simm A. Role of advanced glycation end products in cellular signaling. Redox Biol. 2014;2:411–29.
Nogueira-Machado JA, Volpe CM, Veloso CA, et al. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opin Ther Targets. 2011;15(8):1023–35.
•• Hudson BI, Lippman ME. Targeting RAGE Signaling in inflammatory disease. Annu Rev Med. 2018;69:349–64 This review article discusses the role of RAGE and DAMP in the development of inflammation.
Ibrahim ZA, Armour CL, Phipps S, Sukkar MB. RAGE and TLRs: relatives, friends or neighbours? Mol Immunol. 2013;56(4):739–44.
Huang YJ, Marsland BJ, Bunyavanich S, O'Mahony L, Leung DYM, Muraro A, et al. The microbiome in allergic disease: current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. J Allergy Clin Immunol. 2017;139(4):1099–110.
Gilbert JA, Quinn RA, Debelius J, Xu ZZ, Morton J, Garg N, et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature. 2016;535(7610):94–103.
Yacoub R, Nugent M, Cai W, Nadkarni GN, Chaves LD, Abyad S, et al. Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS One. 2017;12(9):e0184789.
Rosenbaum JT, Asquith MJ. The microbiome: a revolution in treatment for rheumatic diseases? Curr Rheumatol Rep. 2016;18(10):62.
Seiquer I, Rubio LA, Peinado MJ, Delgado-Andrade C, Navarro MP. Maillard reaction products modulate gut microbiota composition in adolescents. Mol Nutr Food Res. 2014;58(7):1552–60.
Corzo-Martínez M, García-Campos G, Montilla A, Moreno FJ. Tofu whey permeate is an efficient source to enzymatically produce prebiotic fructooligosaccharides and novel fructosylated α-galactosides. J Agric Food Chem. 2016;64(21):4346–52.
Bui TP, Ritari J, Boeren S, et al. Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal. Nat Commun. 2015;6:10062.
Hellwig M, Bunzel D, Huch M, Franz CMAP, Kulling SE, Henle T. Stability of individual Maillard reaction products in the presence of the human colonic microbiota. J Agric Food Chem. 2015;63(30):6723–30.
Koh A, De Vadder F, Kovatcheva-Datchary P, et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–45.
McKenzie C, Tan J, Macia L, Mackay CR. The nutrition-gut microbiome-physiology axis and allergic diseases. Immunol Rev. 2017;278(1):277–95.
Sivaprakasam S, Prasad PD, Singh N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther. 2016;164:144–51.
Zeng H, Chi H. Metabolic control of regulatory T cell development and function. Trends Immunol. 2015;36(1):3–12.
Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy. 2015;70(2):241–4.
Wopereis H, Sim K, Shaw A, Warner JO, Knol J, Kroll JS. Intestinal microbiota in infants at high risk for allergy: effects of prebiotics and role in eczema development. J Allergy Clin Immunol. 2018;141(4):1334–42.
Acknowledgements
This study is supported by Kieikai Research Foundation and Japan Society for the Promotion of Science (JSPS) Core-to-Core Program (A. Advanced Research Networks entitled “Establishment of international agricultural immunology research-core for a quantum improvement in food safety".
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no conflicts of interest relevant to this manuscript.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Allergens
Rights and permissions
About this article
Cite this article
Toda, M., Hellwig, M., Henle, T. et al. Influence of the Maillard Reaction on the Allergenicity of Food Proteins and the Development of Allergic Inflammation. Curr Allergy Asthma Rep 19, 4 (2019). https://doi.org/10.1007/s11882-019-0834-x
Published:
DOI: https://doi.org/10.1007/s11882-019-0834-x